{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-092205","form_type":"8-K","ticker":"TELA","cik":"0001561921","company_name":"TELA Bio, Inc.","filed_at":"2023-08-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.313654+00:00","generated_at":"2026-06-11T08:21:53.635716+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"TELA Bio launches OviTex PRS Long-Term Resorbable for plastic and reconstructive surgery","bullets":["OviTex PRS Long-Term Resorbable is intended for soft tissue repair or reinforcement in plastic and reconstructive surgery.","Product supplements existing OviTex PRS portfolio which includes Permanent and Short-Term Resorbable configurations.","Features include bi-directional stretch and a fully resorbable, long-term polymer for reinforcement.","OviTex PRS has over 6,800 implantations at more than 400 healthcare facilities.","CEO Antony Koblish says addition allows surgeons to address indications requiring longer term reinforcement without permanent materials."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-092205","json":"https://secwatch.observer/filing/0001104659-23-092205.json","markdown":"https://secwatch.observer/filing/0001104659-23-092205.md","text":"https://secwatch.observer/filing/0001104659-23-092205.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1561921/000110465923092205/0001104659-23-092205-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1561921/000110465923092205/tm2323862d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T08:21:53.635716+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}